Search

Item 2.02. Results of Operations and Financial Condition. The information in this Item 2.02, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of th

29 Oct 2026 · sec daily index

FEDEX CORP filed 8-K

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 26, 2026, FedEx Corporation (“FedEx” or “the Compan

26 Oct 2026 · sec daily index

ELI LILLY & Co filed 4

SEC form 4 filed by ELI LILLY & Co (CIK 59478) on 2026-10-20.

20 Oct 2026 · sec daily index

ELI LILLY & Co filed 4

SEC form 4 filed by ELI LILLY & Co (CIK 59478) on 2026-10-20.

20 Oct 2026 · sec daily index

ELI LILLY & Co filed 4

SEC form 4 filed by ELI LILLY & Co (CIK 59478) on 2026-10-20.

20 Oct 2026 · sec daily index

ELI LILLY & Co filed SCHEDULE 13G/A

0000316011-26-000036.txt : 20261019 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0000911916-94-000024 0000316011 XXXXXXXX LIVE 47 Common Stock, Without Par Value 09/30/2026 0000059478 ELI LILLY AND COMPANY 53245

19 Oct 2026 · sec daily index

ELI LILLY & Co filed SCHEDULE 13D

pursuant to Rule 424(b)(4) of the Securities Act of 1933, as amended, on October 9, 2026. Common Stock, par value $0.0001 per share TRex Bio, Inc. C/O TREX BIO, INC. 269 EAST GRAND AVENUE SUITE 300 SOUTH SAN FRANCISCO CA

16 Oct 2026 · sec daily index

NEKTAR THERAPEUTICS filed 8-K

Item 8.01 Other Events. In August 2023, Nektar Therapeutics (the Company ) filed a complaint in the U.S. District Court for the Northern District of California (the District Court ) against Eli Lilly and Company ( Lilly

25 Sep 2026 · sec daily index